CompletedPhase 3

Nebulized Morphine in Chest Trauma Patients: A Prospective Study

Tunisia75 participantsStarted 2018-06-14

Plain-language summary

This is a prospective study carried out from 2018 to 2020 including patients aged ≥ 18 years, admitted for isolated chest trauma. Each patient received a nebulization of 10 mg morphine. If Visual Analog Score (VAS) assessed after 10 minutes still\> 4, nebulization was repeated every 10 minutes until pain relief. At 30 minutes, VAS\> 4 means failure.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients aged 18 years and over * victims of isolated chest trauma, * admitted to the intensive care unit Exclusion Criteria: * not consen * pregnant woman * polytrauma * hemodynamic instability with systolic blood pressure less than 100 mmHg, * treated with morphine during transport or in the emergency room * need initial ventilatory support, bradypnea (respiratory rate less than 12 cycles per minute) * allergy to opiods * initial pain Visual Analog Scale (VAS) ≤ 4

What they're measuring

analgesia evaluated with visual scale

Timeframe: 30 minuts

Trial details

NCT IDNCT03580187

SponsorUniversity Hospital, Mahdia

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-04-15

View on ClinicalTrials.gov More Blunt Injury of Thorax trials